• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Avoset to develop infusion pump with unnamed pharma giant

July 12, 2019 By Sarah Faulkner

Avoset Health said this week that it plans to develop a connected infusion pump with an unnamed pharmaceutical company. The product is set to debut in early 2021.

The company touted that its technology allows physicians and pharmacists to track when patients receive infusions, how much drug was infused and which patients need additional intervention.

Users can connect to the pre-programmed infusion pump and begin treatment with the click of a button, Avoset added.

“Our belief is that providing data from the homecare infusion setting will enable providers to make necessary adjustments to the current standard of care for improved patient outcomes,” Avoset CEO Shaul Eitan said in prepared remarks. “Combining our partner’s extensive knowledge, market access and true forward-looking vision with Avoset’s product innovation can advance dedicated infusion towards a value and outcomes-based approach through quantifiable data access.”

“Avoset’s existing technology and Eitan Group’s manufacturing, regulatory and R&D capabilities made Avoset the clear choice to develop the next generation of connected dedicated pump solutions,” a spokesperson from the pharma partner added. “We have complementary expertise; Avoset’s innovation combined with our mature medical and pharmaceutical devices will help patients around the world get more effective treatment.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: avosethealth

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS